Autor: |
Ojas Sharma, Valerie F Civelli, Sarabjeet Singh, Mukul Anand, Vincent Ngo, Sanjiv Sharma |
Rok vydání: |
2019 |
Předmět: |
|
Zdroj: |
Clinical Cardiology and Cardiovascular Interventions. 2:01-03 |
ISSN: |
2641-0419 |
DOI: |
10.31579/2641-0419/034 |
Popis: |
Drug-coated balloons (DCB) are commonly used to treat peripheral artery disease (PAD) and are often used in combination with or in place of a stent or rotational atherectomy. DCB’s are manufactured with the drug, Paclitaxel with the first-line indication of preventing restenosis of arteries following an intervention. Recent literature has suggested an increased mortality risk at years 2 and 5 post DCB angioplasty. Inspired by Katsanos et al. and their important work in researching outcomes for DCBs in PAD, we conducted a thorough review of all literature to compile an informed conclusion. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|